[Alpha Tau in Startup News] Alpha Tau announces Alpha DaRT treatment of first patient with Liver Metastases of Colorectal Cancer
Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that its first patient with liver cancer metastases has been treated in a feasibility and safety study of Alpha DaRT at the McGill University Health Center in Montreal, Canada. Read...
Read More